Sleep in Psychiatric Care (SIP): A Transdiagnostic Group-based Sleep-school as Treatment for Comorbid Insomnia
Launched by HAUKELAND UNIVERSITY HOSPITAL · Jul 3, 2020
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Sleep in Psychiatric Care (SIP) trial is studying a new group-based treatment for people who have both insomnia and psychiatric disorders, such as depression or anxiety. This trial is looking for ways to help patients improve their sleep without using medication, focusing instead on a method called cognitive behavioral therapy for insomnia (CBTi). CBTi includes various strategies like learning about sleep, setting strict sleep schedules, and changing negative thoughts about sleep. The goal is to see how effective this group treatment can be for improving both sleep and mental health symptoms.
To participate in this trial, individuals need to be referred to the sleep school at Bjørgvin DPS psychiatric hospital and meet specific criteria, including having insomnia alongside a moderate to severe psychiatric condition. Key eligibility requirements are based on certain diagnostic guidelines and symptom scores. Participants can expect to be part of a supportive group where they will learn helpful techniques to manage their sleep issues, while researchers gather information to understand the treatment's effectiveness. This trial is currently recruiting participants aged 19 to 74, and it offers a promising approach to tackling common sleep problems in those dealing with mental health challenges.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients referred to the sleep-school at Bjørgvin DPS psychiatric hospital
- • Patients fulfilling the Diagnostic Manual for Mental Disorders (DSM-V) criteria for insomnia comorbid to moderate to severe psychiatric illness (confirmed F-diagnosis based on the International Statistical Classification of Diseases and Related Health Problems (ICD-11) diagnostic system that are used in Norway in addition to insomnia and/or scores of ≥19 on BDI and/or scores of ≥16 on BAI at the time of referral to the sleep school)
- Exclusion Criteria:
- • Nightwork
- • Patients that do not fulfil the DSM-V criteria for insomnia comorbid to moderate to severe psychiatric illness (confirmed F-diagnosis based on the ICD-10 diagnostic system that are used in Norway in addition to insomnia and/or scores of ≥19 on BDI and/or scores of ≥16 on BAI at the time of referral to the sleep school)
About Haukeland University Hospital
Haukeland University Hospital, located in Bergen, Norway, is a leading academic medical center renowned for its commitment to innovative research and high-quality patient care. As a prominent clinical trial sponsor, the hospital leverages its extensive expertise in various medical fields to facilitate cutting-edge clinical studies that aim to advance healthcare outcomes. With a multidisciplinary team of healthcare professionals and researchers, Haukeland University Hospital fosters collaboration and knowledge exchange, ensuring that trials are conducted with the highest standards of ethics, safety, and scientific rigor. Its strategic focus on translational research enhances the bridge between laboratory discoveries and real-world applications, contributing to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bergen, , Norway
Patients applied
Trial Officials
Ane Wilhelmsen-Langeland, PhD
Principal Investigator
Haukeland University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials